Title : Decreased HMGB1 expression contributed to cutaneous toxicity caused by lapatinib.

Pub. Date : 2022 Jul

PMID : 35617997






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The application of lapatinib, a widely used dual inhibitor of human epidermal growth factor receptor 1 (EGFR/ERBB1) and 2 (HER2/ERBB2), has been seriously limited due to cutaneous toxicity. Lapatinib erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 The application of lapatinib, a widely used dual inhibitor of human epidermal growth factor receptor 1 (EGFR/ERBB1) and 2 (HER2/ERBB2), has been seriously limited due to cutaneous toxicity. Lapatinib erb-b2 receptor tyrosine kinase 2 Homo sapiens